Next‑generation UTI diagnostics: delivering results in just 35 minutes

Описание: Urinary Tract infections, or UTIs, affect millions worldwide, driving sepsis, antibiotic overuse, and microbial resistance. Current diagnostics rely on either slow lab cultures or unreliable dipsticks, and often lead to delayed or unnecessary treatment. Llusern’s Lodestar DX changes that: a point-of-care test that detects 96% of key UTI pathogens in just 35 minutes, no lab required.


In this episode I’m joined by Emma Hayhurst who shares her journey into diagnostics, Llusern’s mission, and the emergence of Wales as a biotech hub with a growing life sciences sector fueling local innovation. We discuss UTI prevalence, diagnostic gaps, and how rapid, accurate testing can transform patient care and antimicrobial stewardship. 


02:14               Meet Emma Hayhurst


04:37               Introducing Llusern Scientific


07:21               Collaboration between Llusern and the academy


08:50               The life science ecosystem in Wales


12:10               Urinary tract infections (UTIs)


15:45               UTI patient demographics


16:54               Health impacts of UTIs: sepsis, antibiotic resistance, and more


19:01               Existing UTI diagnostic options and their shortcomings


24:41               Llusern’s Lodestar DX


29:03               A point-of-care test, not a lab test


31:44               Applications beyond UTIs


36:03               Looking forward at Llusern


Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! (https://www.labiotech.eu/advertise/?u...)  


Stay updated by subscribing to our newsletter (https://www.labiotech.eu/newsletter/?...)


To dive deeper into the topic: 

• Life sciences in Wales: biotechs in the scene in 2025 (https://www.labiotech.eu/best-biotech...)
• Fighting Antimicrobial Resistance with Fast Molecular Diagnostics (https://www.labiotech.eu/interview/an...)
• Ultra-Fast Diagnostics Could Transform Sexual Health (https://www.labiotech.eu/in-depth/sti...)